Stockscreener 앱 받기
2.04
4.62%
0.09
전일 마감가:
$1.95
열려 있는:
$1.92
하루 거래량:
71,955
Relative Volume:
0.93
시가총액:
$96.13M
수익:
-
순이익/손실:
$-9.51M
주가수익비율:
-8.16
EPS:
-0.25
순현금흐름:
$-10.96M
1주 성능:
+11.78%
1개월 성능:
+14.61%
6개월 성능:
+46.76%
1년 성능:
+9.68%
1일 변동 폭
$1.92
$2.05
1주일 범위
$1.70
$2.05
52주 변동 폭
$1.12
$2.55
Medicinova Inc Stock (MNOV) Company Profile
명칭
Medicinova Inc
전화
858-373-1500
주소
4275 EXECUTIVE SQUARE, LA JOLLA, CA
MNOV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| MNOV | 2.049 | 96.13M | 0 | -9.51M | -10.96M | -0.25 |
| VRTX | 449.81 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 748.65 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.61 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.57 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.19 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-10 | 개시 | Maxim Group | Buy |
| 2019-03-25 | 재개 | B. Riley FBR | Buy |
| 2018-03-28 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-04-18 | 개시 | Credit Suisse | Outperform |
| 2013-01-04 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-05-24 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2011-10-18 | 재확인 | MLV Capital | Buy |
| 2011-06-22 | 개시 | Global Hunter Securities | Buy |
| 2010-05-12 | 개시 | Wedbush | Outperform |
| 2008-11-12 | 재확인 | Ladenburg Thalmann | Buy |
| 2008-05-15 | 개시 | Rodman & Renshaw | Mkt Outperform |
| 2007-07-09 | 개시 | Punk, Ziegel & Co | Buy |
모두보기
Medicinova Inc 주식(MNOV)의 최신 뉴스
MediciNova reports progress in ALS and Long COVID trials - Investing.com
MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders - GlobeNewswire
MediciNova Partners with NIH for ALS Trial, Reports $42.3M Cash Position | MNOV Stock News - StockTitan
StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV) - Defense World
MediciNova (NASDAQ:MNOV) Coverage Initiated at StockNews.com - MarketBeat
MediciNova Receives Notice of Allowance from United States - GlobeNewswire
MediciNova Secures Key Patent for Diabetes Treatment MN-001 Through 2042 | MNOV Stock News - StockTitan
MediciNova stock hits 52-week high at $2.17 amid growth - Investing.com India
MediciNova: Q3 Earnings Snapshot - New Haven Register
3 US Penny Stocks With Market Caps Over $40M To Consider - Simply Wall St
MediciNova stock hits 52-week high at $2.17 amid growth By Investing.com - Investing.com UK
MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis - The Manila Times
MediciNova Secures Major Settlement from Sanofi-Novartis Litigation, Boosts Clinical Pipeline | MNOV Stock News - StockTitan
Idiopathic Pulmonary Fibrosis Management Market Share and Size Report 2024-2031 - InsightAce Analytic
MediciNova (NASDAQ:MNOV shareholders incur further losses as stock declines 11% this week, taking five-year losses to 80% - Simply Wall St
MediciNova (NASDAQ:MNOV) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at StockNews.com - MarketBeat
TSX Buyback Index (TXBB) QuotePress Release - The Globe and Mail
Idiopathic Pulmonary Fibrosis Market Is Booming Worldwide - openPR
MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com - Defense World
StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV) - MarketBeat
MediciNova (NASDAQ:MNOV) Shares Cross Above Two Hundred Day Moving Average – Should You Sell? - Defense World
MediciNova (NASDAQ:MNOV) Stock Price Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Clean Harbors (CLH-N) QuotePress Release - The Globe and Mail
MediciNova Announces Update of Phase 2/3 Clinical Trial of - GlobeNewswire
MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium) - StockTitan
MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com - MarketBeat
MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com - Defense World
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
MediciNova, Inc. (NASDAQ:MNOV) Shares Sold by Dimensional Fund Advisors LP - Defense World
Type 1 Diabetes Market Report 2034: Epidemiology Data, Pipeline - openPR
MediciNova (NASDAQ:MNOV) shareholders have endured a 73% loss from investing in the stock five years ago - Yahoo Finance
MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
MNOV: MN-166 to be Evaluated in NIH-Sponsored Expanded Access Trial in ALS - Smartkarma
MNOVMedicinova, Inc. Latest Stock News & Market Updates - StockTitan
Short Interest in MediciNova, Inc. (NASDAQ:MNOV) Rises By 19.3% - MarketBeat
MediciNova to Support NIH-Funded Expanded Access Clinical - GlobeNewswire
MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS) - StockTitan
MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving Average of $1.42 - MarketBeat
Amyotrophic Lateral Sclerosis Pipeline Insights, Treatment Drugs, Clinical Trials, and Companies 2024 - The Globe and Mail
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Stockhouse Publishing
Insigneo Advisory Services LLC Has $6.10 Million Stock Position in Mastercard Incorporated (NYSE:MA) - Defense World
Intech Investment Management LLC Takes Position in MSA Safety Incorporated (NYSE:MSA) - MarketBeat
Minerals Technologies (NYSE:MTX) Upgraded at StockNews.com - MarketBeat
Monroe Capital (NASDAQ:MRCC) Stock Crosses Above 200 Day Moving Average of $7.49 - MarketBeat
MARXU stock soars to all-time high of $12.15 amid market optimism - Investing.com Australia
Marcus (NYSE:MCS) Upgraded by StockNews.com to Hold - Defense World
Mistras Group senior EVP sells over $349k in company stock - Investing.com
Contact Levi & Korsinsky by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc.(MGNX) - Stockhouse Publishing
Summit Trail Advisors LLC Buys 403 Shares of Moderna, Inc. (NASDAQ:MRNA) - Defense World
MacroGenics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationMGNX - Longview News-Journal
Medicinova Inc (MNOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.80%
0.42%
자본화:
|
볼륨(24시간):